What We Do

Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer.

Panacea’s novel product is a blood test that can detect the presence of HAAH in serum of humans. HAAH (Human Aspartyl (Asparaginyl) B-Hydroxylase) is an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology.